FDANonrulemakingFDA-2013-P-1153

Who commented on this docket

Requests That the International Non-Proprietary Naming (INN) Policy Equally to all Biologics

7 organizations filed 8 public comments on Requests That the International Non-Proprietary Naming (INN) Policy Equally to all Biologics, at the Food and Drug Administration.

Organizations
7
Comments
8
RIN
Comment window

Commenters (7)

  • Generic Pharmaceutical Associationtrade assoc.
    2 filings · confidence 85%
  • AbbVie Inc.unverified attribution
    1 filing · confidence 70%
  • Global Healthy Living Foundationtrade assoc.
    1 filing · confidence 85%
  • National Association of Boards of Pharmacytrade assoc.
    1 filing · confidence 85%
  • National Council for Prescription Drug Programstrade assoc.
    1 filing · confidence 85%
  • Pharmaceutical Care Management Associationtrade assoc.
    1 filing · confidence 85%
View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.